Tracking the tail

Immune-checkpoint inhibitors have deeply changed the therapeutic landscape of advanced non-small cell lung cancer without actionable genomic alterations. Immune-checkpoint inhibitors have become standard front-line therapy, especially among patients with tumours expressing high levels of programmed...

Descripción completa

Detalles Bibliográficos
Autores principales: Friedlaender, Alex, Liu, Stephen V, Addeo, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473618/
https://www.ncbi.nlm.nih.gov/pubmed/32883870
http://dx.doi.org/10.1136/jitc-2020-000971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473618/
https://www.ncbi.nlm.nih.gov/pubmed/32883870
http://dx.doi.org/10.1136/jitc-2020-000971

Ejemplares similares